Cerliponase Alfa

CAS 1688275-21-8Biologic

Overview

Cerliponase Alfa is a recombinant form of human tripeptidyl peptidase 1 (TPP1) used in enzyme replacement therapy for treating Batten disease, specifically CLN2 type. It acts by supplementing the deficient enzyme in patients, slowing disease progression.

Therapeutic areas

NeurologyGenetic Disorders
Verified Supplier Partner

Do you supply Cerliponase Alfa? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Aripiprazole
43 suppliers
Pregabalin
39 suppliers
Levetiracetam
38 suppliers
Lurasidone Hydrochloride
32 suppliers
Lacosamide
31 suppliers
Lamotrigine
31 suppliers
Escitalopram Oxalate
30 suppliers
Quetiapine Fumarate
29 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo